entertainment -WSS

entertainment

author：focus 2025-10-01 11:34:34 - browse：5644

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Sanofi CEO defends move to abandon profit guidance, boost research

Wikipedia

focus

WSS

Virtual Event: March of the Biosimilars

Stop the failed accountable care organization experiment

The new shift in health care is toward less care

Biotech incubator Curie.Bio graduates its first startup

Intermittent fasting comes with a heart risk? Not so fast

Abortion clinic in Cancun will cater to Americans

hotspot

entertainment

focus

The high cost of giving birth even with insurance

Gene editing the human germline: What are the risks?

Anesthesiologist group: stop taking Ozempic before surgery

The Sacklers, horror, and ‘The Fall of the House of Usher’

Jerome Adams on the need for new antivirals for Covid

HPV cancer vaccine study demonstrates efficacy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The Sacklers, horror, and ‘The Fall of the House of Usher’

Walensky prepares to leave CDC — and Congress — behind

Baby aspirin cuts fat buildup in liver disease patients, in small study

hotspot

FDA approves potent Eli Lilly obesity drug, Zepbound

STAT Executive Editor Rick Berke on STAT's 8th birthday

5 to watch: Tech startups trying to solve health care's staffing crisis

Medicare will require more price transparency from hospitals

MoonLake credibility takes another hit with mid

Extreme heat events are a public health emergency

Wikipedia

explore

focus

leisure time